Review clinical trials related to Glaucoma, Angle-Closure. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
To assure the quality of follow-up and treatment, data of glaucoma patients are stored and evaluated after anonymisation.
manifest glaucoma, ocular Hypertension, glaucoma suspect
under 18 years of age, corneal diseases
This study is designed for single-center, open-label, dose escalation phase I trial to evaluate the safety and tolerability of a single/multiple intravitreal injection of FB1001 in patients with APACG(Acute Primary Angle-Closure Glaucoma) or NAION(Nonarteritic Anterior Ischemic Optic Neuropathy).
Patients with Acute Primary Angle-Closure Glaucoma (APACG) Optic Neuropathy： [+11]
History or current diagnosis of glaucoma in both eyes; [+34]
To evaluate the intraocular pressure reduction effect of combined gonioscopy-assisted transluminal trabeculotomy (GATT) with goniosynechialysis in eyes with secondary synechial angle closure glaucoma.
Patients with secondary synechial angle closure glaucoma [+2]
Eyes with PACG. [+4]